Truist Securities Maintains Hold on National Health Investors, Raises Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on National Health Investors (NHI) while raising the price target from $65 to $78.
August 30, 2024 | 4:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on National Health Investors (NHI) and increased the price target from $65 to $78, indicating a positive outlook.
The increase in price target from $65 to $78 by Truist Securities suggests a positive outlook for NHI, which could lead to a short-term price increase. However, the Hold rating indicates that the stock may not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100